IPG Photonics makes binding offer for Lumibird Medical for EUR 300 million
IPGP•Binding offer for Lumibird Medical
IPG Photonics entered a binding offer to acquire Lumibird Medical for EUR 300 million in cash on a cash-free, debt-free basis.
The deal includes a contingent cash earnout of up to EUR 50 million tied to 2026 and 2027 performance metrics.
Closing is targeted for Q4 2026, subject to customary closing conditions.
Transaction details and expected impact
Lumibird Medical reported 2025 revenue of EUR 112.2 million, EBITDA of EUR 24.1 million, and an EBITDA margin of 21.5%.
The transaction aims to expand IPG’s medical laser platform, combining ophthalmology and urology positions. IPG said the deal is expected to be accretive to margin, EBITDA and adjusted EPS.
